PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
申请人:Bolli Martin
公开号:US20110212998A1
公开(公告)日:2011-09-01
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.
[EN] PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE PYRIDINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2009024905A1
公开(公告)日:2009-02-26
The invention relates to novel pyridine derivatives of formula (I), their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituants are as defined in the claims.
2-Hydroxymethylpyridine, die entsprechenden Pyridin-N-oxide und ihre Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung
申请人:HOECHST AKTIENGESELLSCHAFT
公开号:EP0533130A1
公开(公告)日:1993-03-24
Beschrieben werden Pyridinderivate der allgemeinen Formel (I)
in der Y = Methyl oder CH₂OR⁵ ,
und ihre Verwendung als Arzneimittel zur Anwendung als Fibrosupressiva und zur Beeinflussung des Stoffwechsels von Kollagen und kollagenähnlichen Stoffen.
描述了通式(I)的吡啶衍生物
其中 Y = 甲基或 CH₂OR⁵ 、
以及它们作为纤维抑制剂和影响胶原及胶原样物质代谢的药物用途。
US8598208B2
申请人:——
公开号:US8598208B2
公开(公告)日:2013-12-03
Pyridine derivatives as S1P1/EDG1 receptor modulators
申请人:Bolli Martin
公开号:US08598208B2
公开(公告)日:2013-12-03
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.